ClinicalTrials.govpublic full text
Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease Spectrum
elderly, alzheimer disease, melatonin, cognitive decline, biomarker with neurodegeneration patients, cerebellum, interventional, na
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 894011
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.